164 related articles for article (PubMed ID: 1082545)
1. Effect of levamisole on E-rosette-forming cells in vivo and in vitro in Hodgkin's disease.
Ramot B; Biniaminov M; Shoham C; Rosenthal E
N Engl J Med; 1976 Apr; 294(15):809-11. PubMed ID: 1082545
[TBL] [Abstract][Full Text] [Related]
2. Levamisole in the treatment of Hodgkin's disease.
Berényi E; Kávai M; Szabolcsi M; Szegedi G
Acta Med Acad Sci Hung; 1979; 36(2):177-85. PubMed ID: 317549
[TBL] [Abstract][Full Text] [Related]
3. Restoration of cellular immune response by levamisole in patients with Hodgkin's disease.
Levo Y; Rotter V; Ramot B
Biomedicine; 1975 Jun; 23(6):198-200. PubMed ID: 1082352
[TBL] [Abstract][Full Text] [Related]
4. Effect of levamisole, thymic humoral factor and indomethacin on e-rosette formation of lymphocytes in Hodgkin's disease.
Ramot B; Rosenthal E; Biniaminov M; Ben-Bassat I
Isr J Med Sci; 1981 Apr; 17(4):232-5. PubMed ID: 7195385
[TBL] [Abstract][Full Text] [Related]
5. Interaction between serum factors and T lymphocytes in Hodgkin's disease. Use as a diagnostic test.
Fuks Z; Strober S; Kaplan HS
N Engl J Med; 1976 Dec; 295(23):1273-8. PubMed ID: 185517
[TBL] [Abstract][Full Text] [Related]
6. Restoration of E-rosette formation by levamisole and its abrogation by autochthonous serum from cattle with squamous cell carcinoma of horn.
Dhingra VK; Gupta RK; Sadana JR
Res Vet Sci; 1982 Sep; 33(2):142-5. PubMed ID: 6983096
[TBL] [Abstract][Full Text] [Related]
7. Management of advanced Hodgkin's disease in remission.
Klener P; Hausner P; Donner L
Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(2):213-7. PubMed ID: 6179821
[TBL] [Abstract][Full Text] [Related]
8. Reversal of cell surface abnormalities of T lymphocytes in hodgkin's disease after in vitro incubation in fetal sera.
Fuks Z; Strober S; King DP; Kaplan HS
J Immunol; 1976 Oct; 117(4):1331-5. PubMed ID: 1086325
[TBL] [Abstract][Full Text] [Related]
9. E-rosette inhibiting substance in Hodgkin's disease spleen extracts.
Bieber MM; Fuks Z; Kaplan HS
Clin Exp Immunol; 1977 Sep; 29(3):369-75. PubMed ID: 201408
[TBL] [Abstract][Full Text] [Related]
10. Letter: In-vitro resotration by levamisole of thymus-derived lymphocyte function in Hodgkin's disease.
Biniaminov M; Ramot B
Lancet; 1975 Feb; 1(7904):464. PubMed ID: 48661
[No Abstract] [Full Text] [Related]
11. [T and B lymphocytes in chronic lymphocytic leukemia and Hodgkin's disease. Electron microscopic and immunologic studies].
Cohnen G
Veroff Pathol; 1975; (0):1-99. PubMed ID: 49138
[TBL] [Abstract][Full Text] [Related]
12. The in vitro effect of levamisole on histamine inhibited E-rosette forming T-lymphocyte subpopulation in patients affected by disseminated erythematosus lupus.
Pozsonyi T; Jakab L; Fehér J; Cseh K
Allergol Immunopathol (Madr); 1982; 10(6):435-9. PubMed ID: 6220589
[TBL] [Abstract][Full Text] [Related]
13. The effect of levamisole on E-rosette formation by trypsinized lymphocytes.
Lomnitzer R; Rabson AR
Clin Exp Immunol; 1978 Sep; 33(3):499-502. PubMed ID: 310743
[TBL] [Abstract][Full Text] [Related]
14. [E-RFC (T cells) and Ig-positive cells (B cells) in the peripheral blood of patients with lymphogranulomatosis and possible immunocorrection with levamisole].
Markova TP; Danilova NV
Ter Arkh; 1985; 57(7):15-8. PubMed ID: 3876611
[TBL] [Abstract][Full Text] [Related]
15. In vitro stimulation of T-cell rosette formation by antiserum to thymus factor in Hodgkin's disease.
Zółtowska A; Arendt M; Gan J
Arch Immunol Ther Exp (Warsz); 1984; 32(1):51-7. PubMed ID: 6332594
[TBL] [Abstract][Full Text] [Related]
16. Effect of uremic serum on E-rosette formation of normal lymphocytes modulated by levamisole.
Modai D; Peller S; Weissgarten J; Shaked U; Kaufman S
Isr J Med Sci; 1981 Dec; 17(12):1115-8. PubMed ID: 7327910
[TBL] [Abstract][Full Text] [Related]
17. The in vitro effect of thymic humoral factor and levamisole on peripheral blood lymphocytes in systemic lupus erythematosus patients.
Michalevicz R; Many A; Ramot B; Trainin N
Clin Exp Immunol; 1978 Jan; 31(1):111-5. PubMed ID: 639342
[TBL] [Abstract][Full Text] [Related]
18. Letter: In-vitro restoration by levamisole of thymus-derived lymphocyte functions in Hodgkin's disease.
Verhaegen H; De Cock W; De Cree J; Verbruggen F; Verhaegen-Declercq M; Brugmans J
Lancet; 1975 Apr; 1(7913):978. PubMed ID: 48151
[No Abstract] [Full Text] [Related]
19. Interference of levamisole with inhibition of E-rosette formation by Hodgkin's disease and systemic lupus erythematosus cytotoxic sera.
Del Giacco GS; Tognella S; Leone AL; Locci F; Cornaglia P; Sangiuolo A; Grifoni V
Blood; 1979 May; 53(5):1002-6. PubMed ID: 435634
[TBL] [Abstract][Full Text] [Related]
20. Rosette-forming lymphocytes in Hodgkin's disease.
Cohnen G; Augener W; Brittinger G; Douglas SD
N Engl J Med; 1973 Oct; 289(16):863. PubMed ID: 4543492
[No Abstract] [Full Text] [Related]
[Next] [New Search]
